Published in Gastroenterology on March 21, 2008
Dietary Triggers of Gastrointestinal Symptoms in IBS Patients | NCT03664531
Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol (2009) 2.63
Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med (2012) 2.58
Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol (2012) 1.99
Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol (2009) 1.91
Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS One (2012) 1.74
Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci U S A (2009) 1.67
Celiac disease. Curr Opin Gastroenterol (2010) 1.51
Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci (2009) 1.39
Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophr Res (2014) 1.10
The gluten-free diet and its current application in coeliac disease and dermatitis herpetiformis. United European Gastroenterol J (2015) 1.06
Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat. Diabetologia (2010) 1.06
Effect of gliadin on permeability of intestinal biopsy explants from celiac disease patients and patients with non-celiac gluten sensitivity. Nutrients (2015) 1.06
Review article: coeliac disease, new approaches to therapy. Aliment Pharmacol Ther (2012) 1.04
Recent advances in celiac disease. World J Gastroenterol (2011) 1.03
Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia. Schizophr Res (2013) 1.01
Zonulin, regulation of tight junctions, and autoimmune diseases. Ann N Y Acad Sci (2012) 1.00
Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea. Am J Physiol Gastrointest Liver Physiol (2012) 0.99
Celiac disease and autoimmune-associated conditions. Biomed Res Int (2013) 0.99
Increased plasma zonulin in patients with sepsis. Biochem Med (Zagreb) (2013) 0.98
Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. Clin Gastroenterol Hepatol (2012) 0.98
Discerning the role of Bacteroides fragilis in celiac disease pathogenesis. Appl Environ Microbiol (2012) 0.94
Matriptase protects against experimental colitis and promotes intestinal barrier recovery. Inflamm Bowel Dis (2011) 0.94
Dietary gluten and the development of type 1 diabetes. Diabetologia (2014) 0.94
Particulate matter air pollution causes oxidant-mediated increase in gut permeability in mice. Part Fibre Toxicol (2011) 0.92
Hepatic manifestations of celiac disease. Clin Exp Gastroenterol (2010) 0.91
The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease. Tissue Barriers (2013) 0.91
Celiac disease and autoimmunity: review and controversies. Curr Allergy Asthma Rep (2013) 0.91
Pepsin digest of wheat gliadin fraction increases production of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-κB signaling pathway and an NLRP3 inflammasome activation. PLoS One (2013) 0.90
Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability. Front Immunol (2015) 0.90
Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall. Am J Pathol (2008) 0.89
Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes. Funct Integr Genomics (2012) 0.88
Gut Microbiota and Celiac Disease. Dig Dis Sci (2016) 0.87
Role of Corticotropin-releasing Factor in Gastrointestinal Permeability. J Neurogastroenterol Motil (2015) 0.87
The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate. Therap Adv Gastroenterol (2016) 0.86
Identification of a novel immunomodulatory gliadin peptide that causes interleukin-8 release in a chemokine receptor CXCR3-dependent manner only in patients with coeliac disease. Immunology (2010) 0.86
Anti-gluten immune response following Toxoplasma gondii infection in mice. PLoS One (2012) 0.86
Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. Gastroenterology (2015) 0.86
Antibodies to the wheat storage globulin Glo-3A in children before and at diagnosis of celiac disease. J Pediatr Gastroenterol Nutr (2011) 0.85
Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder. Bipolar Disord (2013) 0.85
Gliadin fragments promote migration of dendritic cells. J Cell Mol Med (2011) 0.85
The dietary intake of wheat and other cereal grains and their role in inflammation. Nutrients (2013) 0.84
Role of CXCR3/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease. PLoS One (2014) 0.83
Activation of p38-MAPK by CXCL4/CXCR3 axis contributes to p53-dependent intestinal apoptosis initiated by 5-fluorouracil. Cancer Biol Ther (2014) 0.83
The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop. J Immunol Res (2015) 0.83
Therapeutic approaches for celiac disease. Best Pract Res Clin Gastroenterol (2015) 0.81
Skin- and gut-homing molecules on human circulating γδ T cells and their dysregulation in inflammatory bowel disease. Clin Exp Immunol (2012) 0.81
Liver involvement in celiac disease. Minerva Med (2008) 0.81
Digested wheat gluten inhibits binding between leptin and its receptor. BMC Biochem (2015) 0.81
Emerging therapeutic options for celiac disease: potential alternatives to a gluten-free diet. Gastroenterol Hepatol (N Y) (2012) 0.80
Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study. J Clin Immunol (2012) 0.80
Animal models to study gluten sensitivity. Semin Immunopathol (2012) 0.80
The Spectrum of Differences between Childhood and Adulthood Celiac Disease. Nutrients (2015) 0.80
A metabolomic perspective on coeliac disease. Autoimmune Dis (2014) 0.80
The Role of Gluten in Celiac Disease and Type 1 Diabetes. Nutrients (2015) 0.79
What role does wheat play in the symptoms of irritable bowel syndrome? Gastroenterol Hepatol (N Y) (2013) 0.79
New and developing therapies for celiac disease. Therap Adv Gastroenterol (2009) 0.79
Celiac disease in patients with type 1 diabetes: a condition with distinct changes in intestinal immunity? Cell Mol Immunol (2011) 0.79
Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells. Clin Exp Immunol (2010) 0.79
Celiac disease: a disorder emerging from antiquity, its evolving classification and risk, and potential new treatment paradigms. Gut Liver (2015) 0.79
Nutritional Keys for Intestinal Barrier Modulation. Front Immunol (2015) 0.79
The Relationship between Serum Zonulin Level and Clinical and Laboratory Parameters of Childhood Obesity. J Clin Res Pediatr Endocrinol (2016) 0.78
Intestinal stem cells and celiac disease. World J Stem Cells (2014) 0.78
Current and emerging therapy for celiac disease. Front Med (Lausanne) (2014) 0.78
Gene Expression Profiling of Gliadin Effects on Intestinal Epithelial Cells Suggests Novel Non-Enzymatic Functions of Pepsin and Trypsin. PLoS One (2013) 0.78
Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers (2016) 0.78
Epithelial transport of immunogenic and toxic gliadin peptides in vitro. PLoS One (2014) 0.78
Important lessons derived from animal models of celiac disease. Int Rev Immunol (2011) 0.78
Elderly Onset Celiac Disease: A Narrative Review. Clin Med Insights Gastroenterol (2016) 0.78
Are alterations of tight junctions at molecular and ultrastructural level different in duodenal biopsies of patients with celiac disease and Crohn's disease? Virchows Arch (2014) 0.77
Maize prolamins could induce a gluten-like cellular immune response in some celiac disease patients. Nutrients (2013) 0.77
Modeling of celiac disease immune response and the therapeutic effect of potential drugs. BMC Syst Biol (2013) 0.77
Circulating Zonulin Correlates with Density of Enteroviruses and Tolerogenic Dendritic Cells in the Small Bowel Mucosa of Celiac Disease Patients. Dig Dis Sci (2016) 0.77
IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia. Brain Behav Immun (2014) 0.76
Gliadin Induces Neutrophil Migration via Engagement of the Formyl Peptide Receptor, FPR1. PLoS One (2015) 0.76
Ancient pathogen-driven adaptation triggers increased susceptibility to non-celiac wheat sensitivity in present-day European populations. Genes Nutr (2016) 0.76
Celiac disease: a model disease for gene-environment interaction. Cell Mol Immunol (2011) 0.76
Potential role of CXCR3 in proliferation and invasion of prostate cancer cells. Int J Clin Exp Pathol (2015) 0.75
Immunopathogenesis and therapeutic approaches in pediatric celiac disease. Expert Rev Clin Immunol (2016) 0.75
Pro-inflammatory Cytokine IFNγ and Microbiome-Derived Metabolites Dictate Epigenetic Switch between FOXP3 Isoforms in Celiac Disease: Regulation of FOXP3 isoforms in celiac disease. Clin Exp Immunol (2016) 0.75
Celiac disease: Alternatives to a gluten free diet. World J Gastrointest Pharmacol Ther (2010) 0.75
Gliadin-Specific T-Cells Mobilized in the Peripheral Blood of Coeliac Patients by Short Oral Gluten Challenge: Clinical Applications. Nutrients (2015) 0.75
Coeliac disease and autoimmune disease-genetic overlap and screening. Nat Rev Gastroenterol Hepatol (2015) 0.75
Bio-physical characteristics of gastrointestinal mucosa of celiac patients: comparison with control subjects and effect of gluten free diet-. BMC Gastroenterol (2011) 0.75
Celiac Disease: Role of the Epithelial Barrier. Cell Mol Gastroenterol Hepatol (2017) 0.75
Human Intestinal Barrier Function in Health and Disease. Clin Transl Gastroenterol (2016) 0.75
Effects of Gliadin consumption on the Intestinal Microbiota and Metabolic Homeostasis in Mice Fed a High-fat Diet. Sci Rep (2017) 0.75
Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model. Ann N Y Acad Sci (2017) 0.75
Celiac disease resolution after allogeneic bone marrow transplantation is associated with absence of gliadin-specific memory response by donor-derived intestinal T-cells. J Clin Immunol (2013) 0.75
Cytoplasmic Form of Carlr lncRNA Facilitates Inflammatory Gene Expression upon NF-κB Activation. J Immunol (2017) 0.75
Soluble Syndecan-1: A Novel Biomarker of Small Bowel Mucosal Damage in Children with Celiac Disease. Dig Dis Sci (2016) 0.75
Toll-like receptor signalling. Nat Rev Immunol (2004) 34.74
Chemokines--chemotactic cytokines that mediate inflammation. N Engl J Med (1998) 12.80
Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med (1997) 7.42
The tight junction: a multifunctional complex. Am J Physiol Cell Physiol (2004) 6.13
A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med (2006) 5.05
Danger signals: SOS to the immune system. Curr Opin Immunol (2001) 3.91
Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med (2000) 3.84
Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science (1996) 3.84
Current concepts of celiac disease pathogenesis. Gastroenterology (2000) 3.23
MyD88-mediated stabilization of interferon-gamma-induced cytokine and chemokine mRNA. Nat Immunol (2006) 3.20
Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet (2000) 2.82
Intraepithelial T cells of the TcR gamma/delta+ CD8- and V delta 1/J delta 1+ phenotypes are increased in coeliac disease. Scand J Immunol (1989) 2.29
Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes (2006) 2.29
Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med (2002) 2.17
Regulation of the T cell response. Clin Exp Allergy (2006) 2.16
Reprogramming of CTLs into natural killer-like cells in celiac disease. J Exp Med (2006) 2.03
Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology (2002) 2.02
Intraepithelial lymphocytes in celiac disease. Am J Gastroenterol (2003) 1.92
Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut (2003) 1.84
Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol (2001) 1.82
Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function. J Biol Chem (2004) 1.81
Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand J Gastroenterol (2006) 1.81
Glutamate receptor ion channels. Curr Opin Neurobiol (2005) 1.79
Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci (2000) 1.78
Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines. Eur J Immunol (2003) 1.74
Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci U S A (2005) 1.65
Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in Celiac disease. J Immunol (2006) 1.51
A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor. Anal Biochem (1997) 1.47
CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis. Mol Cell Biol (2006) 1.42
Evidence for NK cell subsets based on chemokine receptor expression. J Immunol (2006) 1.39
CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma. J Immunol (2000) 1.30
Functional importance of regional differences in localized gene expression of receptors for IL-13 in murine gut. J Immunol (2006) 1.26
Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins. FEBS Lett (2005) 1.25
Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS. Eur J Immunol (2006) 1.25
The pathogenesis of coeliac disease. Int J Biochem Cell Biol (2004) 1.17
Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease. Gut (2006) 1.12
Toxicity of wheat flour proteins and protein-derived peptides for in vitro developing intestine from rat fetus. Pediatr Res (1979) 0.98
Understanding the molecular basis of celiac disease: what genetic studies reveal. Ann Med (2006) 0.98
Affinity purification and partial characterization of the zonulin/zonula occludens toxin (Zot) receptor from human brain. J Neurochem (2000) 0.97
Neutrophil recruitment and barrier impairment in celiac disease: a genomic study. Clin Gastroenterol Hepatol (2007) 0.93
Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines. Br J Pharmacol (2004) 0.89
Targeting the chemokine receptor CXCR3 and its ligand CXCL10 in the central nervous system: potential therapy for inflammatory demyelinating disease? Curr Neurovasc Res (2004) 0.88
gamma/delta T cells in multiple sclerosis: chemokine and chemokine receptor expression. Clin Immunol (2002) 0.81
The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol (2010) 7.47
The DNA sequence of the human X chromosome. Nature (2005) 6.97
Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol (2004) 5.80
The Oslo definitions for coeliac disease and related terms. Gut (2012) 5.76
A critical role for eosinophils in allergic airways remodeling. Science (2004) 5.53
Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr (2005) 5.34
Arthritis critically dependent on innate immune system players. Immunity (2002) 5.31
Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med (2014) 4.64
TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat Immunol (2002) 4.63
Modulation of the antitumor immune response by complement. Nat Immunol (2008) 4.53
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol (2011) 4.23
Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med (2006) 4.23
CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature (2009) 4.03
A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr (2007) 3.91
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev (2009) 3.65
Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites. Immunol Rev (2004) 3.63
Detection of Celiac disease in primary care: a multicenter case-finding study in North America. Am J Gastroenterol (2007) 3.60
Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med (2012) 3.35
Functional roles for C5a receptors in sepsis. Nat Med (2008) 3.33
"BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations. J Clin Oncol (2008) 3.25
Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect (2002) 2.90
Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat Immunol (2005) 2.85
Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7. Proc Natl Acad Sci U S A (2009) 2.76
Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes (2006) 2.29
Dependence of IL-4, IL-13, and nematode-induced alterations in murine small intestinal smooth muscle contractility on Stat6 and enteric nerves. J Immunol (2003) 2.27
Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance. Eur Urol (2008) 2.25
The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc Natl Acad Sci U S A (2002) 2.24
C5a negatively regulates toll-like receptor 4-induced immune responses. Immunity (2005) 2.24
Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J Exp Med (2005) 2.23
The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis. J Exp Med (2007) 2.23
The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals. J Biol Chem (2005) 2.21
Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity. BMC Med (2011) 2.19
Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J Immunol (2003) 2.18
Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med (2002) 2.17
Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies. Eur J Cancer (2012) 2.17
Medium-term outcomes of active surveillance for localised prostate cancer. Eur Urol (2013) 2.16
Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity. J Immunol (2006) 2.16
A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J Clin Invest (2006) 2.15
The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. Immunity (2008) 2.13
Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J Immunol (2002) 2.11
Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J Clin Invest (2004) 2.10
Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages. Gastroenterology (2008) 2.09
BTBD1 and BTBD2 colocalize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5delta. Exp Cell Res (2003) 2.06
Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism. J Immunol (2008) 2.06
Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology (2002) 2.02
Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages. Infect Immun (2007) 1.98
Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide. J Immunol (2003) 1.96
Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol (2005) 1.96
Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVS. Infect Immun (2006) 1.93
Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells. J Cereb Blood Flow Metab (2003) 1.93
Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. J Leukoc Biol (2004) 1.92
Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med (2010) 1.91
C5L2, a nonsignaling C5A binding protein. Biochemistry (2003) 1.90
An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2. J Biol Chem (2005) 1.89
Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J Immunol (2006) 1.88
TLR4/MyD88/PI3K interactions regulate TLR4 signaling. J Leukoc Biol (2009) 1.87
Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J Endotoxin Res (2006) 1.86
Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int Immunol (2004) 1.85
Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid. J Immunol (2013) 1.85
C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy. J Am Soc Nephrol (2009) 1.85
Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J Exp Med (2003) 1.83
CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system. J Immunol (2007) 1.83
Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand J Gastroenterol (2006) 1.81
An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. Am J Pathol (2003) 1.80
Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease. Int Arch Allergy Immunol (2009) 1.78
Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance. J Biol Chem (2007) 1.78
The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature (2013) 1.78
The impact of extramedullary disease at presentation on the outcome of myeloma. Leuk Lymphoma (2009) 1.77
Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS One (2012) 1.74
Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders. Nutrients (2013) 1.74
Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines. Eur J Immunol (2003) 1.74
CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest (2002) 1.73
The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J Biol Chem (2009) 1.73
Complement: a novel factor in basal and ischemia-induced neurogenesis. EMBO J (2006) 1.70
Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus. J Immunol (2006) 1.70
Contribution of interferon-beta to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide. J Biol Chem (2006) 1.70
Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci U S A (2009) 1.67
Role of STAT6 and mast cells in IL-4- and IL-13-induced alterations in murine intestinal epithelial cell function. J Immunol (2002) 1.66
Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci U S A (2005) 1.65